What PEG-MGF is, how PEGylation changes the dosing schedule versus regular MGF, and how that changes what you track and when.
At a glance
PEG-MGF is the pegylated form of Mechano Growth Factor, a splice variant of IGF-1 produced locally in muscle in response to mechanical stress. Regular MGF has a very short half-life — minutes. PEG-MGF attaches a polyethylene glycol group to slow clearance, extending the half-life into days. That single chemical change is the entire reason to use PEG-MGF over MGF, and it has direct implications for how you dose and track it.
In research and animal models, MGF and its pegylated form have been investigated for:
Human data is limited. Most of what is reported in self-experimenter circles is anecdotal recovery improvement, particularly post-training.
Regular MGF requires injection within a tight window post-workout to be useful. PEG-MGF, with its extended half-life, is typically used:
This means your tracking schedule looks different from a daily peptide.
Specific doses vary widely in self-reports and are not prescriptions.
Even though dosing is infrequent, daily logs still matter — because the effect is cumulative:
Peptide IA will let you tag each dose and overlay weekly metric changes against dosing days, which is the cleaner way to read an infrequent-injection protocol.
PEG-MGF is not a steroid. Reported effects are subtle and most visible as faster between-session recovery rather than dramatic mass changes. Anyone selling it as a mass-builder is overstating what the data shows. If you are training poorly or eating in a deficit, no peptide will rescue the outcome.
Week 0: baseline. Standardized strength test, daily recovery metrics, no dose. Weeks 1-6: dosing 1-2x/week, daily and weekly metrics. Weeks 7-10: washout. Same metrics. Does recovery regress?
The cleanest signal is in the washout: if recovery scores drop and strength metrics flatten without the compound, that is your effect size.
Long-acting peptides accumulate. A side effect on day 2 may persist through day 5 because the compound is still circulating. Watch site reactions and any IGF-1-related symptoms carefully and work with a clinician.
Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.